tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

AMGNAmgen

Health care · Biotechnology · Nasdaq

Amgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Company,” “we,” “our” or “us”) discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. 10-K, Item 1

Headquarters
Thousand Oaks, CA
CEO
Robert A. Bradway
Next results
around Feb 2, 2027
Compare with peers → Embed

From 2021 to 2025, CEO pay as reported rose 14% while net income rose 31%. $100 in the shares at the start of the table was worth $167 at the end (peer group: $192). CEO pay over the 5 years: $114.9M.

Fiscal year toCEOCEO pay (reported) CEO pay (actually paid) Other executives, average$100 becamePeer groupNet income Non-gaap, earnings per share, or eps
Dec 31, 2025Mr. Bradway $24.7M$49.4M $8.5M $167$192 $7.7B 21.84
Dec 31, 2024- $24.4M$12.7M $9.8M $129$150 $4.1B 19.36
Dec 31, 2023- $22.6M$29.1M $7.7M $138$138 $6.7B 18.83
Dec 31, 2022- $21.4M$41.7M $7.2M $121$136 $6.6B 17.18
Dec 31, 2021- $21.7M$17.0M $7.4M $101$123 $5.9B 17.69

Pay versus performance table of the proxy statement (DEF 14A) filed Apr 7, 2026, as tagged by the company in XBRL. Open the proxy ↗

Work on AMGN in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/AMGN/export.csv") into a cell.